HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 36.16
-2.54 (-6.56%)
At close: Aug 21, 2026
HitGen Market Cap
HitGen has a market cap or net worth of 14.49 billion as of August 21, 2026. Its market cap has increased by 59.65% in one year.
Market Cap
14.49B
Enterprise Value
13.76B
Revenue
579.37M
Ranking
n/a
PE Ratio
120.31
Stock Price
36.16
ChartMarket Cap Chart
Since April 16, 2020, HitGen's market cap has decreased from 18.86B to 14.49B, a decrease of -23.19%. That is a compound annual growth rate of -4.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 14.49B | 54.68% |
| Dec 31, 2025 | 9.37B | 90.34% |
| Dec 31, 2024 | 4.92B | -17.81% |
| Dec 29, 2023 | 5.99B | 10.86% |
| Dec 30, 2022 | 5.40B | -42.61% |
| Dec 31, 2021 | 9.41B | -22.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 17.58B |
| BrightGene Bio-Medical Technology | 16.82B |
| GemPharmatech | 14.72B |
| Acrobiosystems | 14.34B |
| Jinyu Bio-technology | 14.31B |
| Mabwell (Shanghai) Bioscience | 14.11B |
| Anhui Anke Biotechnology (Group) | 14.10B |
| Sino Biological,Inc. | 13.61B |